NexPlasmaGen’s to present at the Seed showcase 2022
NEXPLASMAGEN TO PRESENT AT SEED SHOWCASE 2022 NexPlasmaGen will pitch its business opportunity to investors! Montreal/De...
24 December, 2021 No commentNEXPLASMAGEN TO PRESENT AT SEED SHOWCASE 2022 NexPlasmaGen will pitch its business opportunity to investors! Montreal/De...
24 December, 2021 No commentNexPlasmaGen is proud to announce that the preclinical trials program led by Dr. Philip Wong at the Centre Hospitaller d...
03 November, 2021 No commentNexPlasmaGen Inc. is pleased to announce that its patented cold plasma technology is in preparation for clinical investi...
02 January, 2021 No commentMontreal/June 23, 2022 – NexPlasmaGen is honored to present at the MedInvest Oncology Investor Conference. The MedInvest...
23 June, 2022 No commentNEXPLASMAGEN TO PRESENT AT THE 2023 OBIO INVESTMENT SUMMIT Canada’s Premier Health Science Investment Event! Montreal/Fe...
02 February, 2023 No commentNexPlasmaGen Inc. is pleased to announce the completion of $795,000 in private and public investment from individuals, A...
01 July, 2018 No commentMontreal / July 4, 2022 NexPlasmaGen is a finalist for the ADRIQ Innovation Award 2022 in the category Innovation from P...
04 July, 2022 No commentNEXPLASMAGEN TO PRESENT AT THE 2022 OBIO INVESTMENT SUMMIT Canada’s Premier Health Science Investment Event! Montreal/Ja...
30 January, 2022 No comment